Logo image of DYAI

DYADIC INTERNATIONAL INC (DYAI) Stock Overview

USA - NASDAQ:DYAI - US26745T1016 - Common Stock

1.3 USD
+0.12 (+10.17%)
Last: 10/1/2025, 8:39:22 PM
1.2699 USD
-0.03 (-2.32%)
After Hours: 10/1/2025, 8:39:22 PM

DYAI Key Statistics, Chart & Performance

Key Statistics
52 Week High2.2
52 Week Low0.71
Market Cap47.05M
Shares36.19M
Float27.05M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.19
PEN/A
Fwd PEN/A
Earnings (Next)11-10 2025-11-10
IPO11-05 2004-11-05
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


DYAI short term performance overview.The bars show the price performance of DYAI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30

DYAI long term performance overview.The bars show the price performance of DYAI in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 -40

The current stock price of DYAI is 1.3 USD. In the past month the price increased by 32.76%. In the past year, price increased by 30%.

DYADIC INTERNATIONAL INC / DYAI Daily stock chart

DYAI Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 23.08 431.71B
AMGN AMGEN INC 13.69 160.70B
GILD GILEAD SCIENCES INC 14.36 137.92B
VRTX VERTEX PHARMACEUTICALS INC 23.86 103.64B
REGN REGENERON PHARMACEUTICALS 13.15 63.59B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 60.38B
ARGX ARGENX SE - ADR 82.78 46.96B
ONC BEONE MEDICINES LTD-ADR 5.86 39.84B
INSM INSMED INC N/A 31.13B
BNTX BIONTECH SE-ADR N/A 24.57B
BIIB BIOGEN INC 9.63 22.61B
NTRA NATERA INC N/A 22.18B

About DYAI

Company Profile

DYAI logo image Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. The company is headquartered in Jupiter, Florida and currently employs 6 full-time employees. The company went IPO on 2004-11-05. The firm's gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica, which the Company named C1. The Compny’s lead technology, C1-cell protein production platform, is based on an industrially proven microorganism (named C1), which is used to speed development and improve performance of biologic vaccines and drugs at flexible commercial scales for the human and animal health markets. The firm has also developed the Dapibus filamentous fungal based microbial protein production platform to enable the rapid development and large-scale manufacture of low-cost proteins, metabolites, and other biologic products for use in non-pharmaceutical applications.

Company Info

DYADIC INTERNATIONAL INC

1044 North U.S. Highway One, Suite 201

Jupiter FLORIDA 33477 US

CEO: Mark A. Emalfarb

Employees: 6

DYAI Company Website

DYAI Investor Relations

Phone: 15617438333

DYADIC INTERNATIONAL INC / DYAI FAQ

What is the stock price of DYADIC INTERNATIONAL INC today?

The current stock price of DYAI is 1.3 USD. The price increased by 10.17% in the last trading session.


What is the ticker symbol for DYADIC INTERNATIONAL INC stock?

The exchange symbol of DYADIC INTERNATIONAL INC is DYAI and it is listed on the Nasdaq exchange.


On which exchange is DYAI stock listed?

DYAI stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for DYADIC INTERNATIONAL INC stock?

7 analysts have analysed DYAI and the average price target is 9.18 USD. This implies a price increase of 606.15% is expected in the next year compared to the current price of 1.3. Check the DYADIC INTERNATIONAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is DYADIC INTERNATIONAL INC worth?

DYADIC INTERNATIONAL INC (DYAI) has a market capitalization of 47.05M USD. This makes DYAI a Nano Cap stock.


How many employees does DYADIC INTERNATIONAL INC have?

DYADIC INTERNATIONAL INC (DYAI) currently has 6 employees.


What are the support and resistance levels for DYADIC INTERNATIONAL INC (DYAI) stock?

DYADIC INTERNATIONAL INC (DYAI) has a resistance level at 1.67. Check the full technical report for a detailed analysis of DYAI support and resistance levels.


Is DYADIC INTERNATIONAL INC (DYAI) expected to grow?

The Revenue of DYADIC INTERNATIONAL INC (DYAI) is expected to grow by 6.98% in the next year. Check the estimates tab for more information on the DYAI EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy DYADIC INTERNATIONAL INC (DYAI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does DYADIC INTERNATIONAL INC (DYAI) stock pay dividends?

DYAI does not pay a dividend.


When does DYADIC INTERNATIONAL INC (DYAI) report earnings?

DYADIC INTERNATIONAL INC (DYAI) will report earnings on 2025-11-10.


What is the Price/Earnings (PE) ratio of DYADIC INTERNATIONAL INC (DYAI)?

DYADIC INTERNATIONAL INC (DYAI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.19).


What is the Short Interest ratio of DYADIC INTERNATIONAL INC (DYAI) stock?

The outstanding short interest for DYADIC INTERNATIONAL INC (DYAI) is 0.35% of its float. Check the ownership tab for more information on the DYAI short interest.


DYAI Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to DYAI. When comparing the yearly performance of all stocks, DYAI is one of the better performing stocks in the market, outperforming 87.73% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

DYAI Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to DYAI. DYAI has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

DYAI Financial Highlights

Over the last trailing twelve months DYAI reported a non-GAAP Earnings per Share(EPS) of -0.19. The EPS increased by 32.14% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -68.51%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%14.29%
Sales Q2Q%150.58%
EPS 1Y (TTM)32.14%
Revenue 1Y (TTM)128.84%

DYAI Forecast & Estimates

7 analysts have analysed DYAI and the average price target is 9.18 USD. This implies a price increase of 606.15% is expected in the next year compared to the current price of 1.3.

For the next year, analysts expect an EPS growth of 10.75% and a revenue growth 6.98% for DYAI


Analysts
Analysts82.86
Price Target9.18 (606.15%)
EPS Next Y10.75%
Revenue Next Year6.98%

DYAI Ownership

Ownership
Inst Owners13.88%
Ins Owners14.79%
Short Float %0.35%
Short Ratio0.54